LoginRegister

    Zydus Cadila gets USFDA nod for swelling reducing drug

    Written by Ruby Khatun Khatun   |  

    New Delhi: Zydus Cadila has received final approval from the US health regulator to market Ethacrynate sodium for injection, used to reduce swelling caused by various diseases.


    The company has received final approval from the US Food and Drug Administration (USFDA) to market the drug in the strength of 50 mg/vial, Zydus Cadila said in a BSE filing.


    The company will produce the drug at its formulations manufacturing facility in Moraiya, Ahmedabad.


    Ethacrynate sodium for injection is used to reduce swelling caused by various diseases including related to liver, kidney, congestive heart failure, and cancer.


    The company has more than 165 approvals and so far filed over 300 abbreviated new drug applications (ANDAs) since it commenced filings in 2003-04

    abbreviated new drug applicationsAhmedabadapprovalcancerEthacrynate sodiumFood and Drug Administrationheart failureindian pharma newsInjectionmarketMoraiyapharma newspharma news indiaswellingswelling reducing drugUSFDAZydus Cadila
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

      © 2020 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X